IceCure Medical Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 64

Employees

  • Stock Symbol
  • ICCM

Stock Symbol

  • Share Price
  • $1.26
  • (As of Friday Closing)

IceCure Medical General Information

Description

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Contact Information

Formerly Known As
Arbel Medical
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • PO Box 3163
  • 7 HaEshel Street
  • Caesarea 38900
  • Israel
+972
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • PO Box 3163
  • 7 HaEshel Street
  • Caesarea 38900
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IceCure Medical Stock Performance

As of 21-Mar-2025, IceCure Medical’s stock price is $1.26. Its current market cap is $70.7M with 56.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.26 $1.25 $0.48 - $1.66 $70.7M 56.6M 369K -$0.28

IceCure Medical Financials Summary

As of 30-Sep-2024, IceCure Medical has a trailing 12-month revenue of $3.67M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 20,267 45,611 55,446 104,255
Revenue 3,671 3,229 3,085 4,138
EBITDA (14,253) (15,253) (16,491) (9,597)
Net Income (13,834) (14,652) (16,978) (9,895)
Total Assets 15,278 16,410 30,188 32,281
Total Debt 486 599 597 909
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IceCure Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IceCure Medical‘s full profile, request access.

Request a free trial

IceCure Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, a
Other Devices and Supplies
Caesarea, Israel
64 As of 2023

Latham, NY
 

Bedford, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IceCure Medical Competitors (12)

One of IceCure Medical’s 12 competitors is Angiodynamics, a Private Debt Financed company based in Latham, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angiodynamics Private Debt Financed Latham, NY
Orbital Therapy Corporation Bedford, MA
Hygea Medical Venture Capital-Backed Beijing, China
Novian Health Venture Capital-Backed Chicago, IL
CPSI Biotech Corporation Owego, NY
You’re viewing 5 of 12 competitors. Get the full list »

IceCure Medical Patents

IceCure Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4520281-A1 Cryoprobe Pending 11-Sep-2023
US-20250082384-A1 Cryoprobe Pending 11-Sep-2023
EP-4309604-A1 Cryogenic system connector Pending 18-Jul-2022
US-20240019058-A1 Cryogenic system connector Active 18-Jul-2022
JP-2024012270-A Low temperature system connector Active 18-Jul-2022 A61B18/02
To view IceCure Medical’s complete patent history, request access »

IceCure Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IceCure Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IceCure Medical‘s full profile, request access.

Request a free trial

IceCure Medical FAQs

  • When was IceCure Medical founded?

    IceCure Medical was founded in 2006.

  • Where is IceCure Medical headquartered?

    IceCure Medical is headquartered in Caesarea, Israel.

  • What is the size of IceCure Medical?

    IceCure Medical has 64 total employees.

  • What industry is IceCure Medical in?

    IceCure Medical’s primary industry is Other Devices and Supplies.

  • Is IceCure Medical a private or public company?

    IceCure Medical is a Public company.

  • What is IceCure Medical’s stock symbol?

    The ticker symbol for IceCure Medical is ICCM.

  • What is the current stock price of IceCure Medical?

    As of 21-Mar-2025 the stock price of IceCure Medical is $1.26.

  • What is the current market cap of IceCure Medical?

    The current market capitalization of IceCure Medical is $70.7M.

  • What is IceCure Medical’s current revenue?

    The trailing twelve month revenue for IceCure Medical is $3.67M.

  • Who are IceCure Medical’s competitors?

    Angiodynamics, Orbital Therapy, Hygea Medical, Novian Health, and CPSI Biotech are some of the 12 competitors of IceCure Medical.

  • What is IceCure Medical’s annual earnings per share (EPS)?

    IceCure Medical’s EPS for 12 months was -$0.28.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »